Being admitted for stem cell collection before an autologous transplant and then hearing that the stay will run longer than planned, with two more collection sessions added, is a common experience. When an ENT (ear, nose and throat) consultation is added on top of that, it can feel as if the whole plan has fallen apart. In most cases, however, these changes reflect an adjustment of sequence rather than a failure of treatment.
Hematopoietic stem cells normally live in the bone marrow. After several days of growth factor injections (G-CSF), or during the recovery phase following chemotherapy, these cells move into the bloodstream. They are then gathered using an apheresis machine, which circulates the blood, separates the layer containing the needed cells, and returns the rest to the body. A single session usually takes several hours, and if the arm veins are not suitable, a temporary collection catheter may be placed in the neck or groin.
The number of sessions is not fixed in advance because the goal is a cell count, not a calendar. Teams measure CD34-positive cells collected per kilogram of body weight. There is a minimum needed for a single transplant, a more comfortable target that supports steadier engraftment, and a higher target when two transplants are planned. If the first day falls short, the blood is rechecked the next morning to decide whether to continue — which is exactly how a short admission becomes a longer one.
Several factors influence how well cells mobilize: age, the number and type of prior chemotherapy regimens, previous radiation to marrow-rich areas, marrow involvement by disease, and how quickly blood counts are recovering. This is not a matter of effort or diet. When yields are low, the team may add a mobilizing agent, adjust the growth factor schedule, or plan another attempt later.
During collection, the anticoagulant used in the circuit can temporarily lower blood calcium, causing tingling around the mouth or in the fingertips, or muscle cramping. Reporting this immediately usually leads to a slower flow rate or calcium supplementation. Platelet counts may drop for a short time, and because sessions require lying still for hours, planning meals and bathroom breaks ahead helps.
The ENT or dental review is about what comes next. Before transplant, high-dose chemotherapy is given, followed by a period when white blood cells — especially neutrophils — fall very low. During that window, a small, quiet infection such as sinusitis, middle ear inflammation, or a chronic root or gum infection can become serious. Finding and treating these sites beforehand is standard preparation. If a procedure or extraction is needed, healing time must be allowed, and the schedule shifts accordingly.
Practical preparation helps. Treat the admission length as flexible when arranging work, caregiving, and travel. After each session, ask three things together: how much was collected today and where the cumulative total stands relative to the target, when tomorrow's decision will be made, and what the options are if the target is not reached. If an ENT issue is found, ask how long treatment will take and how many days it may add before conditioning begins.
Report promptly: fever of 38°C or higher or chills, swelling, pain, bleeding or discharge at the catheter site, tingling or cramping that does not settle, sudden dizziness, palpitations or breathlessness, and new gum, face, or ear pain.
This article provides general health information and does not replace individual diagnosis or care. Collection targets, session numbers, and schedule changes vary from person to person, so please discuss your own plan with your treating medical team.